ATE26214T1 - PHARMACEUTICAL COMPOSITIONS. - Google Patents
PHARMACEUTICAL COMPOSITIONS.Info
- Publication number
- ATE26214T1 ATE26214T1 AT82100354T AT82100354T ATE26214T1 AT E26214 T1 ATE26214 T1 AT E26214T1 AT 82100354 T AT82100354 T AT 82100354T AT 82100354 T AT82100354 T AT 82100354T AT E26214 T1 ATE26214 T1 AT E26214T1
- Authority
- AT
- Austria
- Prior art keywords
- etintidine
- pharmaceutical compositions
- concomitant administration
- pepstatin
- pepsin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/005—Enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Enhanced antiulcer activity is obtained in warm-blooded animals by the concomitant administration of the histamine H2-receptor antagonist, etintidine, and the pepsin complexing agent, pepstatin. Concomitant administration of the two entities reduces the amount of etintidine necessary for effective treatment, thereby decreasing its side effect liability.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/225,945 US4339439A (en) | 1981-01-19 | 1981-01-19 | Pharmaceutical methods and compositions |
EP82100354A EP0056973B1 (en) | 1981-01-19 | 1982-01-19 | Pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE26214T1 true ATE26214T1 (en) | 1987-04-15 |
Family
ID=22846923
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT82100354T ATE26214T1 (en) | 1981-01-19 | 1982-01-19 | PHARMACEUTICAL COMPOSITIONS. |
Country Status (9)
Country | Link |
---|---|
US (1) | US4339439A (en) |
EP (1) | EP0056973B1 (en) |
JP (1) | JPS57139018A (en) |
AT (1) | ATE26214T1 (en) |
CA (1) | CA1199872A (en) |
DE (1) | DE3275903D1 (en) |
DK (1) | DK16282A (en) |
FI (1) | FI820136L (en) |
GR (1) | GR75141B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI832520L (en) * | 1982-07-12 | 1984-01-13 | Bristol Myers Co | PHARMACEUTICAL FORMS AND SAMPLES |
US5833946A (en) * | 1995-06-06 | 1998-11-10 | Bayer Corporation | Dissemination of fungal infections: animal model and method of prophylaxis |
WO2020130205A1 (en) * | 2018-12-21 | 2020-06-25 | 경상대학교병원 | Pharmaceutical composition and health function food comprising pepsin inhibitor |
IT202000012370A1 (en) * | 2020-05-26 | 2021-11-26 | Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L | COMPOSITION INCLUDING PEPSTATIN AND ALGINIC ACID OR A SALT HEREBY AND ITS USE |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4101650A (en) * | 1977-04-06 | 1978-07-18 | Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai | Pepstatin floating minicapsules |
US4112234A (en) * | 1977-08-22 | 1978-09-05 | Bristol-Myers Company | Imidazolylmethylthioethyl alkynyl guanidines |
NZ187376A (en) * | 1977-06-03 | 1981-05-29 | Bristol Myers Co | N-cyano-n-(2-(4-methyl-5-imidazolyl)methylthio)ethyl)-n-alkynyl guanidines intermediates pharmaceutical compositions |
-
1981
- 1981-01-19 US US06/225,945 patent/US4339439A/en not_active Expired - Fee Related
-
1982
- 1982-01-12 CA CA000393983A patent/CA1199872A/en not_active Expired
- 1982-01-15 FI FI820136A patent/FI820136L/en not_active Application Discontinuation
- 1982-01-15 DK DK16282A patent/DK16282A/en not_active Application Discontinuation
- 1982-01-19 GR GR67046A patent/GR75141B/el unknown
- 1982-01-19 DE DE8282100354T patent/DE3275903D1/en not_active Expired
- 1982-01-19 JP JP57005478A patent/JPS57139018A/en active Granted
- 1982-01-19 EP EP82100354A patent/EP0056973B1/en not_active Expired
- 1982-01-19 AT AT82100354T patent/ATE26214T1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JPS57139018A (en) | 1982-08-27 |
GR75141B (en) | 1984-07-13 |
US4339439A (en) | 1982-07-13 |
EP0056973B1 (en) | 1987-04-01 |
FI820136L (en) | 1982-07-20 |
EP0056973A1 (en) | 1982-08-04 |
DE3275903D1 (en) | 1987-05-07 |
DK16282A (en) | 1982-07-20 |
CA1199872A (en) | 1986-01-28 |
JPH0250883B2 (en) | 1990-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8606289A1 (en) | Anti-virally active pyridazinamines. | |
IT1190402B (en) | INOSITOL-TRIPHOSPHATE | |
NL192564B (en) | Device for administering medicaments to patients. | |
MD1367C2 (en) | Methods of B-cells lymphoma treatment, anti-CD20 antibodies, hybridoma | |
ATE157251T1 (en) | USE OF INOSITOL TRIPHOSPHATE TO TREAT INFLAMMATION | |
ES8507567A1 (en) | Stabilized gamma globulin concentrate. | |
NL7806486A (en) | LYOFILIZED NATURAL GAMMA GLOBULIN PREPARATION FOR INTRAVENOUS ADMINISTRATION. | |
ATE47523T1 (en) | PHARMACEUTICAL COMPOSITIONS. | |
ATE182271T1 (en) | MEDICINAL PRODUCTS FOR THE TREATMENT OF CANCER, AIDS AND VIRUS DISEASES | |
NO890046L (en) | DISUBSTITUTED PYRIDINES. | |
ATE26214T1 (en) | PHARMACEUTICAL COMPOSITIONS. | |
NL187893B (en) | SPERMICIDE PREPARATION FOR TOPICAL USE. | |
MY100486A (en) | Compositions comprising pepstatin and histamine h2-receptor antagonist having an enhanced antiulcer activity | |
DK0862454T3 (en) | CTLA-8 in combination with G-CSF or with G-CSF and IL-6 and use of CTLA-8 to treat infections | |
EP0093497A3 (en) | Anthelmintic treatment | |
ES2018387A6 (en) | Monoclonal antibody for inhibiting cell infection by hiv viruses. | |
IT8421820A0 (en) | PREPARATION OF 3,3,3-TRIFLUORO-2-TRIFLUOROMETHYLPRO PENIS. | |
FR3628M (en) | Amylopectin sulfates, useful as pepsin inhibitors and antiulcer agents. | |
ES8302457A1 (en) | Pharmaceutical preparations and manufacature. | |
JPS55113721A (en) | Immunity regulator | |
DE3484155D1 (en) | FR-900216 COMPONENT, OBTAINED BY CULTIVATING ATCC 20577, USED AS ACTIVE THERAPEUTIC COMPOUND, AND ANTITUMORAL PHARMACEUTICAL COMPOSITION CONTAINING IT. | |
ATE87482T1 (en) | PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CEREBRAL PSYCHO-ORGANIC SYNDROMES. | |
ES8700940A1 (en) | Improvements relating to the treatment control and prevention of rhinovirus infections. | |
ATE12228T1 (en) | GUANIDINE PYRIMIDINES. | |
JPS5780327A (en) | Carcinostatic agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |